<DOC>
	<DOCNO>NCT00222833</DOCNO>
	<brief_summary>This 2-year study propose examine effect aripiprazole heart health factor serum lipid , serum leptin , fast blood sugar , body weight blood pressure . This study also examine safety switch aripiprazole respect change clinical state , preexist emergent side-effects , brain process information change social functioning quality life .</brief_summary>
	<brief_title>The Effect Switching Aripiprazole Heart Health Overweight Obese Patients With Schizophrenia</brief_title>
	<detailed_description>This 2-yr study propose examine effect switch subject conventional atypical antipsychotic agent Aripiprazole cardiovascular health index overweight obese patient Schizophrenia Schizoaffective disorder . Thirty partially remit patient Positive Negative Syndrome Scale ( PANSS ) score less 100 , body mass index ( BMI ) 26 high switch exist antipsychotic aripiprazole 2-3 week period use clinician determine cross-tapering approach.The objective study examine cardiovascular health index serum lipid , serum leptin , fast blood sugar , body weight blood pressure . This study also examine safety switch Aripiprazole respect change clinical state , preexist emergent side-effects , brain process information change social functioning quality life .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Male female subject age 1865 year Outpatients stable partial hospital patient Diagnostic Statistical Manual Mental Disorders , Fourth Edition , Text Revision ( DSMIVTR ) diagnosis schizophrenia schizoaffective disorder No psychiatric hospitalization 30 day prior study start Partially remit patient PANSS score 100 screen Currently stable dose one antipsychotic least 30 day prior study start Currently receive stable dose psychotropic medication least 30 day prior study start BMI great 26 Female patient childbearing age must use acceptable method birth control least 1 month prior participation research study continue least 4 week final study visit . Ability provide inform consent . Mental retardation Current treatment clozapine Currently enrol weight management program receive pharmacological treatment weight reduction Serious unstable medical illness Female patient pregnant , lactate , plan become pregnant study period Concurrently receive treatment ketoconazole , quinidine , carbamazepine .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Schizoaffective disorder</keyword>
	<keyword>Aripiprazole</keyword>
	<keyword>Obese</keyword>
	<keyword>Overweight</keyword>
	<keyword>Heart Health</keyword>
	<keyword>Antipsychotic</keyword>
	<keyword>Heart Health Factors</keyword>
	<keyword>Cardiovascular Health Indices</keyword>
	<keyword>Cardiovascular health</keyword>
</DOC>